Search For "sii"
SII's Covovax gets DCGI emergency use nod for children between 7-12 years
Updated : 1 week, 1 day ago IST
New Delhi [India], June 28 (ANI): The Drugs Controller General of India (DCGI) has given restricted emergency use authorisation (EUA) to Pune-based Serum Institute of India's COVID-19 vaccine 'Covovax' for children aged 7 to 12 years, sources told ANI.
Read More
Sai International Institute of Hotel Management invites applications for s
Updated : 2 weeks, 2 days ago IST
Chennai (Tamil Nadu) [India] June 20 (ANI/NewsVoir): Sai International Institute of Hotel Management, a reputed Chennai-based educational institution, has the best credentials for offering value-based and job-oriented hospitality education.
Read More
SEC recommends India's first indigenously developed vaccine against cervic
Updated : 3 weeks ago IST
New Delhi [India], June 15 (ANI): The subject expert committee meeting that was scheduled today to discuss Serum Institute of India's (SII) indigenously developed Quadrivalent human papillomavirus (qHPV) vaccine against cervical cancer, has recommended regular market authorisation for above
Read More
SEC to discuss India's first indigenously developed vaccine against cervic
Updated : 3 weeks, 1 day ago IST
New Delhi [India] June 15 (ANI): The first indigenously developed quadrivalent human papillomavirus (qHPV) vaccine against cervical cancer by the Serum Institute of India (SII) will be discussed by the Subject expert committee on Wednesday.
Read More
COVID-19 vaccine Covovax now available for children in India: Adar Poonawa
Updated : 2 months ago IST
New Delhi [India], May 3 (ANI): Serum Institute of India (SII) CEO Adar Poonawalla on Tuesday said that the COVID-19 vaccine Covovax is now available in India for children.
Read More
SEC seeks more data from Serum Institute over COVID vaccine Covovax for 7-
Updated : 2 months, 1 week ago IST
New Delhi [India], April 30 (ANI): The Drugs Controller General of India's (DCGI) subject expert committee on Friday sought more data from Pune based Serum Institute of India (SII) on the Covovax vaccine for the age group of 7-12 years.
Read More
NTAGI approves SII's Covovax COVID vaccine for 12-17 age group: Sources
Updated : 2 months, 1 week ago IST
New Delhi [India], April 29 (ANI): National Technical Advisory Group on Immunisation (NTAGI) on Friday approved Serum Institute of India's Covovax COVID-19 vaccine for the age group 12-17, said sources.
Read More
Indian jab in my arms, says UK PM; hails COVID-19 vaccine collaboration
Updated : 2 months, 2 weeks ago IST
New Delhi [India], April 22 (ANI): British Prime Minister Boris Johnson on Friday highlighted the collaboration between Oxford-Astra Zeneca and the Serum Institute of India (SII) for the production of COVID-19 vaccines and emphasised that he has "the Indian jab" in his arms.
Read More
Indian COVID vaccines better than Pfizer, Moderna says Adar Poonawalla
Updated : 2 months, 3 weeks ago IST
New Delhi [India], April 13 (ANI): Serum Institute of India (SII) CEO Adar Poonawalla on Wednesday claimed that "Made in India" COVID-19 vaccines have provided more protection against the coronavirus infection than mRNA vaccines like Pfizer and Moderna.
Read More
India is now better prepared to fight any Covid-19 variant, says SII's Ada
Updated : 2 months, 3 weeks ago IST
New Delhi [India], April 12 (ANI): As some countries are presently reporting higher COVID-19 cases, Chief Executive Officer of Serum Institute of India (SII) Adar Poonawalla on Tuesday said that India is better prepared to face it now than it was in 2020.
Read More
SII's Adar Poonawalla says Covovax first Indian COVID vaccine to be sold i
Updated : 2 months, 3 weeks ago IST
New Delhi [India], April 12 (ANI): Chief Executive Officer (CEO) of Serum Institute of India (SII) Adar Poonawalla on Tuesday informed that the company has exported nearly 40 million COVID vaccine doses to European countries and Australia, and said that the Covovax is the first vaccine made
Read More
Slashed COVID-19 vaccine Covishield's prices to ensure more accessibility,
Updated : 2 months, 3 weeks ago IST
New Delhi [India], April 12 (ANI): The decision to slash the prices of the precautionary dose of the COVID-19 vaccine Covishield, which is now available for all adults, was taken to make it more affordable, accessible and within reach of the masses, Chief Executive Officer (CEO) of Serum
Read More
